[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS6150990A - Stable glycoside composition - Google Patents

Stable glycoside composition

Info

Publication number
JPS6150990A
JPS6150990A JP17349284A JP17349284A JPS6150990A JP S6150990 A JPS6150990 A JP S6150990A JP 17349284 A JP17349284 A JP 17349284A JP 17349284 A JP17349284 A JP 17349284A JP S6150990 A JPS6150990 A JP S6150990A
Authority
JP
Japan
Prior art keywords
glycoside
substrate
nonionic surfactant
present
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP17349284A
Other languages
Japanese (ja)
Other versions
JPH0145360B2 (en
Inventor
Noboru Mitsuhida
光飛田 登
Fumie Uno
宇野 文江
Shinichi Tejima
手嶋 真一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyobo Co Ltd
Original Assignee
Toyobo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyobo Co Ltd filed Critical Toyobo Co Ltd
Priority to JP17349284A priority Critical patent/JPS6150990A/en
Publication of JPS6150990A publication Critical patent/JPS6150990A/en
Publication of JPH0145360B2 publication Critical patent/JPH0145360B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

PURPOSE:A stable glycoside composition, containing a glycoside and a nonionic surfactant in a specific proportion respectively in a buffer solution or water, useful as a substrate for measuring reagent for alpha-amylase activity by the conjugated enzymic method. CONSTITUTION:A stable glycoside composition obtained by adding (A) 0.2-100 mg/ml, preferably 0.5-10mg/ml glycoside, preferably beta-2,4-dichlorophenylmaltopentoxide, and (B) >=0.2vol%, preferably 0.3-1.2vol% nonionic surfactant, preferably having 11-18HLB value, e.g. polyoxyethylene isooctyl phenyl ether, and if necessary (C) a color former, e.g. 4-aminoantipyrine, to a buffer solition, e.g. 0.05M PIPES buffer solution of 6.7pH, or water.

Description

【発明の詳細な説明】 (産業上の1・u用分野ン 本発明は安定な配糖体組成物に関するものであシ、さら
に詳しくに共役酵素法を利用するα−アミラーゼ活性測
定試薬の基質として有用な配糖体に関するものである。
DETAILED DESCRIPTION OF THE INVENTION (Industrial Field 1) The present invention relates to a stable glycoside composition, and more particularly to a substrate for a reagent for measuring α-amylase activity using a coupled enzyme method. The present invention relates to glycosides useful as glycosides.

(従来の技術) 血清、尿、膵液等の体液を対象とするα−アミラーゼ活
性の6111足は、臨床篩断上重要な意義を有しており
、特に急性或は慢性の膵炎、膵臓癌、更には流行性耳下
腺炎等の鑑別診断に肖っては必須の測定項目となってい
る〇 従来、提案されているα−アミラーゼ活性の測定法の中
で共役酵素法が最近注目されている。共゛役酵素法とし
ては、特に特開昭53−11092号公報、特開昭54
−25893号公報、特開昭54−51892号公報に
開示されているようなオリゴ循の還元性末端にp−ニト
ロフェノール、4−メチルウンベリフェロンを代表とす
る吸光性及び感光性のフェノール性ヒドロキシル基を有
する化合物がグリコシド結合した配糖体を基質として用
いる方法が特に優れ、実用化inている。また%開餡5
6−35998号公報に開示されているようなオリゴ、
塘の還元性末端に2.4−ジクロロフェノール等のフェ
ノール性ヒドロキシル基を有する化合物でろって、例え
ば4−アミノアンチピリン等と酸化縮合して有色色素全
生成するものがグリコシド結合し几オリゴ糖アグリコン
として用いる方法も実用化てれている。
(Prior art) The α-amylase activity in body fluids such as serum, urine, and pancreatic juice has important clinical significance, especially in acute or chronic pancreatitis, pancreatic cancer, Furthermore, it has become an essential measurement item in the differential diagnosis of mumps, etc. Among the previously proposed methods for measuring α-amylase activity, the coupled enzyme method has recently attracted attention. There is. As the conjugate enzyme method, in particular, JP-A-53-11092, JP-A-54
Light-absorbing and light-sensitive phenolic compounds, such as p-nitrophenol and 4-methylumbelliferone, are added to the reducing end of the oligocyclic chain as disclosed in Japanese Patent Application Laid-Open No. 54-25893 and Japanese Patent Application Laid-Open No. 54-51892. A method using a glycoside in which a compound having a hydroxyl group is glycosidic bonded as a substrate is particularly excellent and has been put into practical use. Also % Kaian 5
Oligos as disclosed in Publication No. 6-35998,
Compounds that have a phenolic hydroxyl group such as 2,4-dichlorophenol at the reducing end of the tang, for example, can be oxidized and condensed with 4-aminoantipyrine to produce a colored pigment, resulting in glycosidic bonds and oligosaccharide aglycones. A method for using it as a method has also been put into practical use.

(発明の解決しようとする問題点) 法によるα−アミラーゼ活性測定法では、基質の溶液安
定性が十分なものではなく、数日ないし数週間にわmっ
て使用する場合、保存中にシいて基質が分解して試薬ク
ランクの上昇、更には基質量不足金主ずることがある。
(Problems to be Solved by the Invention) In the α-amylase activity measurement method, the solution stability of the substrate is not sufficient, and when used for several days or weeks, the The substrate may decompose during this process, resulting in an increase in reagent crank and even a lack of substrate amount.

C問題点七屏決するtめの手段ノ 本発明者らは基質を含む溶液の安定化を計る目的で種々
検討したところ、特定濃度のノニオン界面活性剤全配合
すると基質が著しく安定化すること全見出し、本発明に
到達し几。
The inventors of the present invention conducted various studies for the purpose of stabilizing a solution containing a substrate, and found that the substrate was significantly stabilized when all nonionic surfactants were added at a specific concentration. Heading, reaching the present invention.

すなわち本発明は全組成物に対して0.2〜10019
 / lIeの配砧体および全組成物に対して0.2容
量−以上のノニオン界面活性剤を含有する緩衝液又は水
からなることを特徴とする安定な配糖体組成物である。
That is, the present invention provides 0.2 to 10019 for the entire composition.
The present invention is a stable glycoside composition characterized in that it consists of a buffer solution or water containing 0.2 volumes or more of a nonionic surfactant based on the total composition.

本発明における配砧体は、繰返し皐位数が1〜10であ
るマルトオリゴ糖の還元性末端ヒドロキシ基に対し、グ
ルコース以外の化合物がグリコシド結合しtものである
。グリコシド結合はα−結合、β−結合のいずnでもよ
い。ここでマルトオリゴ糖としては、例えばマルトース
、マルトトリオース、マルトテトラオース、マルトペン
タオース、マルトヘキサオース、マルトヘプタオースな
どかあジ、特にマルトテトラオース、マルトペンタオー
ス、マルトヘキサオース、マルトペンタオースが好まし
い8 本発明におけるマルトオリゴ循に結・片し定アグリコン
としては、グルコシダーゼの作用により遊離し、:S#
することにより呈色するか、あるいは定量が容易なもの
であれば何nでも工゛いが、特に水酸基を有する芳香族
化合物が好ましい。
The atom in the present invention is one in which a compound other than glucose is glycosidic bonded to the reducing terminal hydroxy group of a maltooligosaccharide having 1 to 10 repeating positions. The glycosidic bond may be either an α-bond or a β-bond. Examples of malto-oligosaccharides include maltose, maltotriose, maltotetraose, maltopentaose, maltohexaose, maltoheptaose, and especially maltotetraose, maltopentaose, maltohexaose, and maltopentaose. Preferably 8, the aglycone that binds and separates from malto-oligo circulation in the present invention is released by the action of glucosidase, :S#
Any compound may be used as long as it develops a color or is easy to quantify, but aromatic compounds having a hydroxyl group are particularly preferred.

不発明のマルトオリゴ璧の還元性木端にα−ま几はβ−
結合Gてより結合した水り況基t°灯する芳香族化合物
としてに、フェノールの外に、ハaゲン原+、ヒl’−
ロキシ基、炭素原子数1〜6のアルキル基、アルコキシ
基、アルコキシカルボニル基板fcハニトロ基を有する
フェノール類であり、例えばクロロフェノール、ジクロ
ロフェノール、ヒドロキシフェノール、アルキルフェノ
ール、アルコキシフェノール、安息香叡またはニトロフ
ェノール、ハロゲン化ニトロフェノール、アルキル化ニ
トロフェノール、アルコキシ化ニトロフェノール、ニト
ロ化安息香酸、ジニトロフェノールなトカ挙げられる。
α− is β− at the reducible end of the uninvented malto-oligo.
In addition to phenol, as aromatic compounds that light the water condition group t° bound by the bond G, there are
Phenols having a roxy group, an alkyl group having 1 to 6 carbon atoms, an alkoxy group, an alkoxycarbonyl substrate fc hanitro group, such as chlorophenol, dichlorophenol, hydroxyphenol, alkylphenol, alkoxyphenol, benzoin or nitrophenol, Examples include halogenated nitrophenol, alkylated nitrophenol, alkoxylated nitrophenol, nitrated benzoic acid, and dinitrophenol.

17t 4−メチル−ウンベリフェロンなどの芳香族化
合物であってもよい。
It may also be an aromatic compound such as 17t 4-methyl-umbelliferone.

特に少なくとも1つのニドr:1基を有するフェノール
類、例えば4−二トロフェノール、2−クロロ−4−ニ
トロフェノール、2.6−ジクロロ−4−ニトロフェノ
ール、2.6−ジプロモー4−二トロフェノール、2−
7一ロ%−4−二トロフェノール、2−ニトロフェノー
ル、2−ヒドロキシ−4−二トロフェノール、3−ヒド
ロキシ−4−ニトロフェノールなどが好ましい。
In particular phenols having at least one nitro:1 group, such as 4-ditrophenol, 2-chloro-4-nitrophenol, 2,6-dichloro-4-nitrophenol, 2,6-dipromo-4-nitrophenol. Phenol, 2-
7%-4-nitrophenol, 2-nitrophenol, 2-hydroxy-4-nitrophenol, 3-hydroxy-4-nitrophenol, and the like are preferred.

次に本発明の配鳴体で史に4体例によって説明すると、
例えば下記の様なものが挙げられる。
Next, to explain the sounding body of the present invention using four examples,
Examples include the following.

α−72ニルペンタオサイド、α−2−クロロフェニル
ペンタオサイド、α−2,6−シクロロフズニルベンタ
オサイド、α−4−二トロフ1ニルペンタオサイド、α
−2−クロロ−4°−ニトロフェニルペンタオサイド、
α−2−メチル−4−二トロフェニルペンタオサイドな
どがtりシ、ま几これらのβ−結合体、!几はテトラオ
シド、ヘキサオシド、ペンタオサイドなどがある。こわ
らの混合物でめってもよい。
α-72nylpentaoside, α-2-chlorophenylpentaoside, α-2,6-cyclofuzunylbentaoside, α-4-nitrof1nylpentaoside, α
-2-chloro-4°-nitrophenylpentaoside,
These β-conjugates include α-2-methyl-4-nitrophenylpentaoside, etc.几includes tetraoside, hexaoside, and pentaoside. You can also mix it with a mixture of kowara.

マルトオリゴ用は置換基、例えばハロゲン、アルコキシ
カルボニル基、脂肪族又は芳:香族基を結合しtスルホ
ニル基、脂肪族又は芳香族基上に合したカルボニル基、
フェニル基又ハグルコース残基が1.6−結合したマル
トオリゴ糖でもよく、またマルトオリゴf!鎖の2個の
水酸基が分子内架橋結合したものなど、部分的に修飾さ
れているものも含む。
For malto-oligos, substituents such as halogens, alkoxycarbonyl groups, aliphatic or aromatic groups are bonded, t-sulfonyl groups, carbonyl groups bonded on aliphatic or aromatic groups,
Maltooligosaccharides with 1,6-linked phenyl groups or haglucose residues may be used, and maltooligosaccharides with f! It also includes partially modified chains, such as those in which two hydroxyl groups are intramolecularly cross-linked.

不発+14において、配糖体は全組成物に対して0.2
〜100q/、r、好ましくは0.5〜10翌′27贋
l當有させる。
In misfire +14, glycosides are 0.2 to the total composition
~100 q/r, preferably 0.5~10 q/r, preferably 0.5~10 q/r.

基質に対するα−アミラーゼのミカエリス定数(Km 
)値がJI30.3 mMであり、通常)(mの3〜1
0倍の基“pH1722度下で測定さnることか基準と
なるか、検査分析に供ぜら几る基質溶故中の8度どして
は更にこn、の1〜20倍であることが好ましい。
Michaelis constant (Km) of α-amylase for substrate
) value is JI30.3mM, normal)(m3~1
It is 1 to 20 times higher than 0 times the standard value when measured at a pH of 1722 degrees, or 8 degrees during the substrate dissolution to be submitted for inspection and analysis. It is preferable.

本発明VC令いて用いるノニオン界面活性剤としては、
HLB値が11〜18の範囲のものであれば何でもよい
が、囲えばポリオキシエチレン−p −インオクチルフ
ェニルエーテル、ポリオキシエチレンラウリルエーテル
、ポリオキシュテレ/ラウリルエステル、ポリオキシエ
チレン−p−ノニルフェニルエーテル、ポリオキシエチ
レンセチルエーテルなどがろる。
The nonionic surfactant used in the VC of the present invention includes:
Anything with an HLB value in the range of 11 to 18 is acceptable, but examples include polyoxyethylene-p-yneoctylphenyl ether, polyoxyethylene lauryl ether, polyoxythere/lauryl ester, and polyoxyethylene-p-nonyl. Phenyl ether, polyoxyethylene cetyl ether, etc.

不発明において、ノニオン界面活性剤は全組成物に対し
て0.2容fJt%以上、好まり、 (は0・3〜1・
2容量饅含有ざぜる。通常、血液等の体液全測定する之
めの臨床瑛査試系においては体液中の脂質、蛋白グ:1
等に起因する混濁の影響を低減するために、界面活性剤
を添加することが一般に実施で几でいるが、この目的の
ために添加する界面活性剤の世は通常0.28 ffL
’ S未満である。本発明ではノニオン界面活性剤を全
組成物に対して0.2答i3%以上含有させることによ
り、基質である配糖体の安定fヒを行なうことができる
。0.2容t%未満では安定化を行なうことができない
In the invention, the nonionic surfactant is preferably 0.2 volume fJt% or more based on the total composition, (0.3 to 1.
Contains 2 volumes of rice cake. Normally, in a clinical laboratory test system that measures all body fluids such as blood, lipids and proteins in body fluids: 1
In order to reduce the effects of turbidity caused by
' Less than S. In the present invention, by containing the nonionic surfactant in an amount of 0.2% or more based on the total composition, the glycoside that is the substrate can be stabilized. If the amount is less than 0.2 t% by volume, stabilization cannot be achieved.

本発明の組成物は上記配糖体およびノニオン界面活性剤
のほかに、緩衝液又は水全含む。
In addition to the above glycoside and nonionic surfactant, the composition of the present invention contains a buffer or water.

本発明では配糖体を溶解ざぜt緩衝液又は水にノニオン
界面活性剤を加えてもよいし、又ノニオン界面活性剤を
溶解ざぜ7’C緩衝液又は水に配糖体を加えてもよい。
In the present invention, a nonionic surfactant may be added to the buffer solution or water in which the glycoside is dissolved, or the glycoside may be added to the buffer solution or water in which the nonionic surfactant is dissolved. .

さらに緩衝液又は水に同時に配糖体とノニオン界面活性
剤全添加してもよい。
Furthermore, the glycoside and the nonionic surfactant may all be added to the buffer or water at the same time.

本発明の配糖体の組成物には必要により発色剤、例えば
4−7ミノアンチビリンなど、酵素、例えばα−グルコ
シダーゼ、β−グルコシダーゼなど、駿化剤、例えば過
ヨウ素酸す) IJウムなどが含Mされていてもよい。
The glycoside composition of the present invention may optionally contain a coloring agent such as 4-7 minoantibiline, an enzyme such as α-glucosidase, β-glucosidase, etc., a hydrating agent such as periodic acid, etc. M may be included.

本発明の配糖本組成物は体液中のα−アミラーゼ活性測
定の基質として利用し得る0 (発明の効果) 本発明ではノニオン界面活性剤を全組成物に対して0.
2容′&チ以上含有させることにより、配劇体の安定性
向上させることができる。特にノニオン界面活性剤が0
.1谷t%では保管日数(25℃り1日で安定性が失な
われるに比して、ノニオン界面活性剤が0.2容f#チ
以上では7日以上安定に保管することができる。
The glycoside composition of the present invention can be used as a substrate for measuring α-amylase activity in body fluids. (Effects of the Invention) In the present invention, a nonionic surfactant is added to the entire composition.
By containing more than 2 volumes, the stability of the array element can be improved. In particular, nonionic surfactants are 0.
.. At 1 t%, stability is lost after storage (1 day at 25°C), but when the nonionic surfactant is at 0.2 volume f# or more, it can be stored stably for 7 days or more.

C実施列ン 以下本発明全実施例により説明する。C implementation column The present invention will be explained below with reference to all embodiments.

実施例] ビペス緩衝液(pH6,7) 0.05Mにβ−2,4
−ジクロロフェニルマルトペンタオサイド4μmole
/−および4−アミノアンチピリン4μmole/dt
−加えて基質含有緩fr′fcf、を得た。仄いてトリ
トン−X(ポリオキシエチレンインオクチルフェニルエ
ーテルノを0.6各8%又は1.2容量チ又は第1表に
示さnるノニオン界面活性剤t−添加して基質試液とし
几。
Example] Bipes buffer (pH 6,7) 0.05M with β-2,4
-4 μmole of dichlorophenyl maltopentaoside
/- and 4-aminoantipyrine 4 μmole/dt
- In addition, a substrate-containing loose fr'fcf was obtained. Then, 0.6% each of Triton-X (polyoxyethylene octylphenyl ether) or 1.2 volumes of a nonionic surfactant shown in Table 1 was added to prepare a substrate reagent solution.

得らnT:、基質試液の安定性を測るために下記酵素試
液および発色液全開いて、仄の操作にエフ吸光度全測足
した。
Obtained nT: In order to measure the stability of the substrate reagent solution, the following enzyme reagent solution and coloring solution were fully opened, and the F absorbance was totally measured in the same manner as above.

試薬組成 ■酵素貢液 ピペス緩衝液       0.05 M (pH6,
7〕α−グルコシダーゼ      100u/srβ
−グルコシダーゼ       10u/−トリトンX
−100(ポリオキシエチレンインオクチルフェニルエ
ーテル)      l)、1%■発色液 ホウ酸緩衝液       0.1 M (pH8,4
)過ヨウ素酸ナトリウム水溶液10ミリモル/l検体2
0μlt−試験管にとり酵素試液0,5dと混合し、3
7℃で約5分間加温し九〇次いで基質試液0.5df添
加し、37℃で正確に10分間710@した後、発色液
2.0mt−添加し、5分間放置の後、吸光度を波長5
00nmで測定しt0 本操作全検体の代りに水20μEを用いる場合(試薬ブ
ランフッと2.4−ジクロルフェノール2ミリモル/!
含有する水溶液上用いる場合(標準〕についても繰返し
測定し、得られた吸光度から次式に従ってα−アミラー
ゼ値を計算により求めた。
Reagent composition ■ Enzyme solution Pipes buffer 0.05 M (pH 6,
7] α-glucosidase 100u/srβ
-Glucosidase 10u/-Triton X
-100 (polyoxyethylene octylphenyl ether) l), 1% ■ Coloring liquid borate buffer 0.1 M (pH 8,4
) Sodium periodate aqueous solution 10 mmol/l sample 2
0 μlt - Transfer to a test tube and mix with 0.5 d of enzyme reagent solution,
After heating at 7℃ for about 5 minutes, add 0.5df of the substrate sample solution, incubate at 37℃ for exactly 10 minutes, add 2.0mt of the coloring solution, and after leaving it for 5 minutes, measure the absorbance at the wavelength. 5
Measured at 00nm, t0 This procedure When using 20μE of water instead of all the samples (reagent blank and 2,4-dichlorophenol 2 mmol/!
When used on an aqueous solution (standard), the measurement was repeated, and the α-amylase value was calculated from the obtained absorbance according to the following formula.

前記種々の基質試液全4℃及び25℃に保管した場合の
試薬ブランクの変化を第1表に示す。試薬ブランクが経
日的に上昇することは該基質(β−2,4−ジクロロフ
;ニルマルトペンタオサイトノが分解して結果的に2.
4−ジクロロフェノールが生成していることに対応する
。故に本発明による試液は配糖体が安定化されているこ
とが明らかである。
Table 1 shows the changes in the reagent blank when all of the various substrate reagent solutions described above were stored at 4°C and 25°C. The increase in the reagent blank over time is due to the decomposition of the substrate (β-2,4-dichlorophene;
This corresponds to the production of 4-dichlorophenol. Therefore, it is clear that the glycosides in the test solution according to the present invention are stabilized.

以−j・″余白 g 1 表I-j・″margin g 1 Table

Claims (1)

【特許請求の範囲】[Claims] 全組成物に対して0.2〜100mg/mlの配糖体お
よび全組成物に対して0.2容量%以上のノニオン界面
活性剤を含有する緩衝液又は水からなることを特徴とす
る安定な配糖体組成物。
A stable composition comprising a buffer solution or water containing 0.2 to 100 mg/ml of glycoside based on the total composition and 0.2% by volume or more of a nonionic surfactant based on the total composition. glycoside composition.
JP17349284A 1984-08-21 1984-08-21 Stable glycoside composition Granted JPS6150990A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17349284A JPS6150990A (en) 1984-08-21 1984-08-21 Stable glycoside composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17349284A JPS6150990A (en) 1984-08-21 1984-08-21 Stable glycoside composition

Publications (2)

Publication Number Publication Date
JPS6150990A true JPS6150990A (en) 1986-03-13
JPH0145360B2 JPH0145360B2 (en) 1989-10-03

Family

ID=15961509

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17349284A Granted JPS6150990A (en) 1984-08-21 1984-08-21 Stable glycoside composition

Country Status (1)

Country Link
JP (1) JPS6150990A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63183595A (en) * 1986-10-07 1988-07-28 ベーリング・ダイアグノステイツクス・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング Aromatic substituted glycoside
JP2011083237A (en) * 2009-10-16 2011-04-28 Eiken Chemical Co Ltd Potentiation of color development reaction and/or fluorescent color development reaction with egg yolk liquid

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63183595A (en) * 1986-10-07 1988-07-28 ベーリング・ダイアグノステイツクス・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング Aromatic substituted glycoside
JPH0672149B2 (en) * 1986-10-07 1994-09-14 ヘキスト・セラニーズ・コーポレイシヨン Aromatic substituted glycosides
JP2011083237A (en) * 2009-10-16 2011-04-28 Eiken Chemical Co Ltd Potentiation of color development reaction and/or fluorescent color development reaction with egg yolk liquid

Also Published As

Publication number Publication date
JPH0145360B2 (en) 1989-10-03

Similar Documents

Publication Publication Date Title
US4233403A (en) Amylase assay
JPS6365314B2 (en)
US4698300A (en) Process and reagent for the determination of α-amylase
JPS6183195A (en) Novel oligosaccharide derivative and determination of alpha-amylase using same as a substrate
JPS60237998A (en) Method of measurement of alpha-amylase activity
JP2807949B2 (en) Reagent for measuring α-amylase activity and measuring method
JPH0631293B2 (en) Malto-oligosaccharide derivative and reagent for measuring amylase activity
CA1104912A (en) Method and test kit for serum amylase assay
JPS6150990A (en) Stable glycoside composition
JP3075377B2 (en) Method for measuring α-amylase activity and reagent for measuring α-amylase activity
EP0260414B1 (en) Method of differential assay for alpha-amylase isozymes and a kit for the same
JP2542251B2 (en) Stable one-part α-amylase assay reagent
US4902621A (en) Test reagent for amylase determination
JPS5913199B2 (en) Amylase activity measurement method
JPS5913198B2 (en) Amylase activity measurement method
JP3120892B2 (en) Reagent for measuring α-amylase activity
JP3627817B2 (en) α-Amylase activity measuring method and reagent composition thereof
US5470715A (en) Composition for determination of chloride ion
JPS6317895A (en) Novel oligosaccharide derivative and determination of alpha-amylase activity using same
JPH0113840B2 (en)
JPS63214193A (en) Production of 6-glucosylmaltooligosaccharide derivative and measurement of alpha-amylase activity using said derivative
JP2871034B2 (en) Composition for chlorine ion measurement
JP2770892B2 (en) Alkoxymethylidene maltooligosaccharide derivatives, reagents for measuring α-amylase activity using the same as active ingredients, and methods for measuring α-amylase activity using the same
JP3901990B2 (en) Reagent for measuring α-amylase activity and measurement method
JPH0779718B2 (en) Method for measuring α-amylase activity

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees